Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

7.42

+0.04 (0.54%)

At close: Jun 27, 2025, 4:00 PM

7.44

+0.02 (0.27%)

After-hours: Jun 27, 2025, 6:08 PM EDT

Gyre Therapeutics Market Cap

Gyre Therapeutics has a market cap or net worth of $672.67 million as of June 27, 2025. Its market cap has decreased by -29.89% in one year.

Market Cap

672.67M

Enterprise Value

644.37M

1-Year Change

-29.89%

Ranking

#2753

Market Cap Chart

Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $672.67M, an increase of 306.69%. That is a compound annual growth rate of 7.57%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	691.90M	-38.86%
Dec 31, 2024	1.13B	1,640.92%
Dec 29, 2023	65.00M	291.57%
Dec 30, 2022	16.60M	-42.16%
Dec 31, 2021	28.70M	-79.41%
Dec 31, 2020	139.40M	70.00%
Dec 31, 2019	82.00M	-12.95%
Dec 31, 2018	94.20M	60.20%
Dec 29, 2017	58.80M	653.85%
Dec 30, 2016	7.80M	-78.21%
Dec 31, 2015	35.80M	-60.31%
Dec 31, 2014	90.20M	-35.43%
Dec 31, 2013	139.70M	-5.10%
Dec 31, 2012	147.20M	-20.82%
Dec 30, 2011	185.90M	-75.52%
Dec 31, 2010	759.30M	31.14%
Dec 31, 2009	579.00M	551.29%
Dec 31, 2008	88.90M	-49.97%
Dec 31, 2007	177.70M	2.72%
Dec 29, 2006	173.00M	4.59%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	713.81B
Johnson & Johnson	365.75B
AbbVie	329.95B
Novo Nordisk	299.93B
UnitedHealth Group	274.52B
Novartis AG	235.02B
Abbott Laboratories	232.56B
AstraZeneca	215.99B

Market Cap Rankings